A carregar...
ACTR-48. CLINICAL DEVELOPMENT TARGETING AXL IN RECURRENT GLIOBLASTOMA
Glioblastoma (GBM) is a lethal disease without effective therapies. Previously we reported that the TAM receptor tyrosine kinase family member AXL is upregulated in mesenchymal GBM and its knockdown induces apoptosis of mesenchymal but not proneural glioma sphere cultures (GSCs). In this study, we r...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847660/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.090 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|